Infection control measures: | Studies: |
---|---|
Temperature screening prior to entry | Bastanhagh et al. [38] Ngiam et al. [49]; Canning et al. [36]; Fritsche et al. [45]; Lee et al. [46]; Lee et al. [47]; Samaraseke et al. [40] |
Health declaration forms (travel history, contact tracing) | Bastanhagh et al. [38]; Boursicot et al. [35]; Canning et al. [36]; Ngiam et al. [49] |
PCR testing two days beforehand | Lee et al. [46] |
Examination held in non-clinical institute | Bastanhagh et al. [38]; Bauer et al. [44]; Boursicot et al. [35]; Canning et al. [36]; Fritsche et al. [45]; Lee et al. [46]; Lee et al. [47]; Lengerke et al. [48]; Samaraseke et al. [40] |
Social distancing | Bastanhagh et al. [38]; Bauer et al. [44]; Boursicot et al. [35]; Canning et al. [36]; Fritsche et al. [45]; Lee et al. [46] |
Masks | Bastanhagh et al. [38]; Ngiam et al. [48]; Bauer et al. [44]; Boursicot et al. [35]; Canning et al. [36]; Lee et al. [46]; Lengerke et al. [48]; Nourkami-Tutdibi et al. [50]; Samaraseke et al. [40]; |
Hand hygiene | Canning et al. [36]; Lee et al. [46]; Nourkami-Tutdibi et al. [50]; Samaraseke et al. [40] |
Equipment disinfectant | Bastanhagh et al. [38]; Ngiam et al. [49]; Bauer et al. [44]; Canning et al. [36]; Lee et al. [46]; Nourkami-Tutdibi et al. [50] |
Using reusable bedding gowns | |
Reduced number of participants onsite | Ashokka et al. [42, 43]; Bastanhagh et al. [38]; Boursicot et al. [35]; Canning et al. [36]; Fritsche et al. [45] |
Cohorting (staff from one clinical institute participate in one OSCE circuit separate to other circuits created for other clinical institutes) | Ashokka et al. [42, 43]; Boursicot et al. [35]; Ngiam et al. [49]; Samaraseke et al. [40] |
Examiners examined remotely using videoconferencing software (Fig. 2) |